Smartphone-powered iontophoresis-microneedle array patch for controlled transdermal delivery
Open Access
- 28 December 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Microsystems & Nanoengineering
- Vol. 6 (1), 1-14
- https://doi.org/10.1038/s41378-020-00224-z
Abstract
The incidence rate of diabetes has been increasing every year in nearly all nations and regions. The traditional control of diabetes using transdermal insulin delivery by metal needles is generally associated with pain and potential infections. While microneedle arrays (MAs) have emerged as painless delivery techniques, the integration of MA systems with electronic devices to precisely control drug delivery has rarely been realized. In this study, we developed an iontophoresis-microneedle array patch (IMAP) powered by a portable smartphone for the active and controllable transdermal delivery of insulin. The IMAP in situ integrates iontophoresis and charged nanovesicles into one patch, achieving a one-step drug administration strategy of “penetration, diffusion and iontophoresis”. The MA of the IMAP is first pressed on the skin to create microholes and then is retracted, followed by the iontophoresis delivery of insulin-loaded nanovesicles through these microholes in an electrically controlled manner. This method has synergistically and remarkably enhanced controlled insulin delivery. The amount of insulin can be effectively regulated by the IMAP by applying different current intensities. This in vivo study has demonstrated that the IMAP effectively delivers insulin and produces robust hypoglycemic effects in a type-1 diabetic rat model, with more advanced controllability and efficiency than delivery by a pristine microneedle or iontophoresis. The IMAP system shows high potential for diabetes therapy and the capacity to provide active as well as long-term glycemic regulation without medical staff care.Keywords
This publication has 50 references indexed in Scilit:
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2012
- Approaches for breaking the barriers of drug permeation through transdermal drug deliveryJournal of Controlled Release, 2012
- Modulated iontophoretic delivery of small and large molecules through microchannelsInternational Journal of Pharmaceutics, 2012
- Dissolving polymeric microneedle arrays for electrically assisted transdermal drug deliveryJournal of Controlled Release, 2012
- Simultaneous basal-bolus delivery of fast-acting insulin and its significance in diabetes managementNanomedicine: Nanotechnology, Biology and Medicine, 2012
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2010
- Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulinJournal of Controlled Release, 2009
- Molecular charge mediated transport of a 13kD protein across microporated skinInternational Journal of Pharmaceutics, 2009
- Iontophoresis of lecithin vesicles of cyclosporin AInternational Journal of Pharmaceutics, 2004
- Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year studyDiabetes Research and Clinical Practice, 1995